In-house Organization
Designated Public Office Holders who participated in the communication:
-
Jennifer Pelley,
Director
| Office of Legislative and Regulatory Affairs
|
Health Canada (HC)
-
Kathy Soltys,
Director, Office of Clinical Trials
| Pharmaceutical Drug Directorate
|
Health Canada (HC)
-
Rita Beregszaszy,
Director
| Bureau of Policy, Science, and International Programs
|
Health Canada (HC)
-
Karen Reynolds,
Director General
| PHARMACEUTICAL DRUGS DIRECTORATE
|
Health Canada (HC)
-
Cesare Spadaccini,
Manager,Operational Policy
| OFFICE OF CONTROLLED SUBSTANCES
|
Health Canada (HC)
Subject Matter of the communication:
Health,
Justice and Law Enforcement,
Science and Technology,
International Trade
Communication date:
2024-04-30
Posted date:
2024-05-08
Communication number:
372370-602195
View associated registration
